Heparanase as a Target in Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
14
Page:
286-293
Author(s):
Valentina Masola, Maria Francesca Secchi, Giovanni Gambaro and Maurizio Onisto
Cardiac Side Effects of Chemotherapy: State of Art and Strategies for a Correct Management
Journal:
Current Vascular Pharmacology
Volume:
12
Page:
106-116
Author(s):
Cinzia Perrino, Gabriele G. Schiattarella, Fabio Magliulo, Federica Ilardi, Giuseppe Carotenuto, Giuseppe Gargiulo, Federica Serino, Marco Ferrone, Fernando Scudiero, Andreina Carbone, Bruno Trimarco and Giovanni Esposito
Caspase-8 as a Regulator of Tumor Cell Motility
Journal:
Current Molecular Medicine
Volume:
14
Page:
246-254
Author(s):
R.P. Graf, N. Keller, S. Barbero and D. Stupack
The Interaction Between FAK, MYCN, p53 and Mdm2 in Neuroblastoma
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
14
Page:
46-51
Author(s):
Alicia M. Waters and Elizabeth A. Beierle
Ewing’s Sarcoma Cancer Stem Cell Targeted Therapy
Journal:
Current Stem Cell Research & Therapy
Volume:
9
Page:
46-62
Author(s):
Roumiana Todorova
Vaccine Adjuvants: Key Tools for Innovative Vaccine Design
Journal:
Current Topics in Medicinal Chemistry
Volume:
13
Page:
2562-2580
Author(s):
Peggy Riese, Kai Schulze, Thomas Ebensen, Blair Prochnow and Carlos A. Guzmán
Mining Sarcomas by Proteomics Approaches: Ewing Sarcoma on the Spotlight
Journal:
Recent Patents on Biotechnology
Volume:
7
Page:
98-111
Author(s):
Carlos Mackintosh and Juan Madoz-Gúrpide
Designing Novel Therapies Against Sarcomas in the Era of Personalized Medicine and Economic Crisis
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
5344-5361
Author(s):
Maria Cristina Manara, Cecilia Garofalo, Stefano Ferrari, Antonino Belfiore and Katia Scotlandi
Biomarkers and Novel Therapeutic Targets in Gastrointestinal Stromal Tumors (GISTs)
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
8
Page:
288-297
Author(s):
Nathalia C. Campanella, Antonio T. de Oliveira, Cristovam Scapulatempo-Neto, Denise P. Guimaraes and Rui M. Reis
The Histone Deacetylase Inhibitor, MS-275 (Entinostat), Downregulates c-FLIP, Sensitizes Osteosarcoma Cells to FasL, and Induces the Regression of Osteosarcoma Lung Metastases
Journal:
Current Cancer Drug Targets
Volume:
13
Page:
411-422
Author(s):
Krithi Rao-Bindal, Nadezhda V. Koshkina, John Stewart and Eugenie S. Kleinerman